News
Matt Stoller newsletter reports on Fideres’s original investigation into Steinway
In his weekly BIG Newsletter, Matt Stoller reported on Fideres’s “fascinating report” into Steinway’s monopolization of the...
Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. The coverage of Fideres’s work comes as the Department of Justice continues their investigation into alleged collusion by drug manufacturers.
The full article can be found here.
In his weekly BIG Newsletter, Matt Stoller reported on Fideres’s “fascinating report” into Steinway’s monopolization of the...
We at Fideres are happy to see the European Commission publish “Exploring Aspect of the State of Competition in the EU”. This overa...
Today, Fideres’s research has been cited in a Business Insider article on Blackstone’s BREIT Valuation Issue, Fideres’s original ...
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611
Madrid: +34 919 494 330